特宝生物
(688278)
| 流通市值：178.99亿 | | | 总市值：178.99亿 |
| 流通股本：4.08亿 | | | 总股本：4.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,732,374,422.43 | 1,836,563,644.13 | 797,791,349.65 | 3,695,567,867.63 |
| 营业收入 | 2,732,374,422.43 | 1,836,563,644.13 | 797,791,349.65 | 3,695,567,867.63 |
| 二、营业总成本 | 2,140,546,580.56 | 1,279,195,984.7 | 608,608,067.39 | 2,481,201,979.55 |
| 营业成本 | 318,619,418.48 | 203,143,447.58 | 84,135,622.69 | 259,990,596.78 |
| 税金及附加 | 35,193,498.76 | 23,572,839.63 | 10,147,658.67 | 19,964,915.13 |
| 销售费用 | 996,224,328.82 | 668,309,988.2 | 328,374,104.33 | 1,451,400,170.59 |
| 管理费用 | 279,442,985.35 | 186,072,149.42 | 92,126,614 | 363,909,982.98 |
| 研发费用 | 505,063,893.61 | 196,797,734.9 | 93,643,656.62 | 388,025,752.66 |
| 财务费用 | 6,002,455.54 | 1,299,824.97 | 180,411.08 | -2,089,438.59 |
| 其中:利息费用 | 11,839,569.14 | 2,443,097.52 | 686,786.07 | 1,424,517.72 |
| 其中:利息收入 | 4,315,850.12 | 2,194,075.75 | 904,206.22 | 4,042,479.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 849,030.35 | 509,982.19 | 3,890.42 | 3,448,015.83 |
| 加:投资收益 | 2,698,282.63 | 2,298,419.1 | 1,658,683.69 | 6,599,263.41 |
| 资产处置收益 | 1,660,577.95 | 1,660,577.95 | 626,708.78 | -718,026.13 |
| 信用减值损失(新) | -450,741.61 | -276,133.06 | 581,909 | -60,363.66 |
| 其他收益 | 13,047,973.87 | 9,183,118.04 | 6,579,864 | 27,008,206.26 |
| 四、营业利润 | 609,632,965.06 | 570,743,623.65 | 198,634,338.15 | 1,250,642,983.79 |
| 加:营业外收入 | 390,516.11 | 348,075.84 | 142,855.12 | 1,157,219.52 |
| 减:营业外支出 | 62,895,777.5 | 41,604,279.87 | 19,737,063.74 | 76,425,422.26 |
| 五、利润总额 | 547,127,703.67 | 529,487,419.62 | 179,040,129.53 | 1,175,374,781.05 |
| 减:所得税费用 | 69,764,740.86 | 52,960,473.61 | 14,545,654.32 | 144,138,528.47 |
| 六、净利润 | 477,362,962.81 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 477,362,962.81 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 477,362,962.81 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 |
| 扣除非经常损益后的净利润 | 510,662,711.33 | 488,115,653.17 | 165,332,467.09 | 1,062,128,487.04 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.18 | 1.17 | 0.4 | 2.53 |
| (二)稀释每股收益 | 1.17 | 1.16 | 0.4 | 2.52 |
| 九、综合收益总额 | 477,362,962.81 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 |
| 归属于母公司股东的综合收益总额 | 477,362,962.81 | 476,526,946.01 | 164,494,475.21 | 1,031,236,252.58 |
| 公告日期 | 2026-10-23 | 2026-08-19 | 2026-04-29 | 2026-03-27 |
| 审计意见(境内) | | | | 标准无保留意见 |